F19.950 Other psychoactive substance use, unspecified with psychoactive substance-induced psychotic disorder with delusions

Name of the Condition

• Other Psychoactive Substance Use, Unspecified with Psychoactive Substance-Induced Psychotic Disorder with Delusions
• ICD-10 Code: F19.950

Summary

This condition involves the use of a psychoactive substance not classified under more specific categories (e.g., alcohol, cannabis, opioids) where the substance is unidentified, and a psychotic disorder with delusions is present. It is classified as "unspecified" when the exact agent is unknown or not documented, and "with psychoactive substance-induced psychotic disorder with delusions" indicates the presence of delusional symptoms directly resulting from substance use.

Causes

The condition may result from experimentation, recreational use, or habitual consumption of various psychoactive substances. These substances can alter perception, mood, cognition, or behavior, though the specific agent is not specified. Psychotic symptoms, including delusions, arise when the substance’s effects disrupt normal brain function.

Risk Factors

• Peer pressure or cultural acceptance of substance use.
• Stressful life circumstances or co-occurring mental health conditions (e.g., anxiety, depression).
• Availability of and access to psychoactive substances.
• History of substance use disorders or prior psychotic episodes.

Symptoms

Symptoms vary based on the substance but may include altered perception, mood swings, impaired judgment, or changes in behavior. Delusions—fixed false beliefs not based in reality—are a key feature of the psychotic disorder.

Diagnosis

Diagnosis typically involves a clinical assessment, including patient history and behavioral observations. Lab tests may be used if the substance identity is unknown, though no specific tests are standard. The presence of delusions and their temporal relationship to substance use are critical for confirmation.

Treatment Options

• Counseling and Behavioral Therapies: Aim to modify substance use behaviors and address underlying triggers.
• Medication: Antipsychotics may be used to manage delusions, with careful monitoring for interactions with the unidentified substance.
• Support Groups: Provide community and peer support for recovery.

Prognosis and Follow-Up

Prognosis depends on the duration of substance use, severity of delusions, and adherence to treatment. Regular follow-up is essential to monitor for relapse, manage symptoms, and adjust interventions as needed.

Complications

• Worsening of psychotic symptoms or development of persistent delusions.
• Increased risk of self-harm or harm to others due to impaired judgment.
• Co-occurring substance use disorders or other mental health conditions.

Lifestyle & Prevention

• Avoiding known psychoactive substances and environments where they are used.
• Seeking stress management techniques or therapy to address underlying triggers.
• Building a support network to reduce isolation and peer pressure.

When to Seek Professional Help

Seek immediate care if delusions lead to dangerous behavior, severe distress, or inability to function. Persistent or worsening symptoms, even after substance use stops, also warrant evaluation.

Tips for Medical Coders

Document the presence of delusions and their link to substance use to support the code. Ensure the substance is unspecified (not identified) and that psychotic symptoms are directly induced by the substance. Include details on the nature of delusions and any associated impairment for accurate coding.